Joint (NASDAQ:JYNT) Stock Rating Reaffirmed by Roth Mkm

Roth Mkm reaffirmed their buy rating on shares of Joint (NASDAQ:JYNT) in a research report report published on Friday morning, Benzinga reports. They currently have a $16.00 price objective on the stock, up from their previous price objective of $13.00.

Separately, TheStreet cut Joint from a c- rating to a d rating in a report on Thursday, March 7th. Three analysts have rated the stock with a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of Hold and an average price target of $23.00.

Joint Price Performance

JYNT stock traded up $3.26 during trading on Friday, hitting $16.12. The stock had a trading volume of 261,792 shares, compared to its average volume of 50,014. The company’s 50-day moving average price is $12.05 and its two-hundred day moving average price is $10.14. Joint has a twelve month low of $7.31 and a twelve month high of $16.43. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.08.

Joint (NASDAQ:JYNT) last posted its quarterly earnings results on Thursday, March 7th. The company reported $0.07 earnings per share for the quarter, topping the consensus estimate of $0.03 by $0.04. Joint had a negative net margin of 9.24% and a positive return on equity of 3.76%. The firm had revenue of $30.61 million for the quarter, compared to the consensus estimate of $29.63 million. As a group, equities research analysts anticipate that Joint will post 0.13 EPS for the current fiscal year.

Hedge Funds Weigh In On Joint

Several large investors have recently modified their holdings of the business. Quantbot Technologies LP raised its holdings in Joint by 345.0% in the 3rd quarter. Quantbot Technologies LP now owns 4,170 shares of the company’s stock valued at $37,000 after buying an additional 3,233 shares during the period. Barclays PLC lifted its holdings in shares of Joint by 29.4% in the 3rd quarter. Barclays PLC now owns 13,725 shares of the company’s stock worth $123,000 after acquiring an additional 3,119 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. increased its holdings in Joint by 43.3% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 16,506 shares of the company’s stock valued at $148,000 after purchasing an additional 4,987 shares during the last quarter. WINTON GROUP Ltd purchased a new stake in Joint in the third quarter valued at approximately $179,000. Finally, Strs Ohio increased its stake in Joint by 69.1% during the third quarter. Strs Ohio now owns 25,200 shares of the company’s stock worth $226,000 after purchasing an additional 10,300 shares during the period. Institutional investors and hedge funds own 76.88% of the company’s stock.

About Joint

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.